Enterprise League logo
HuidaGene Therapeutics Logo

HuidaGene Therapeutics

Shanghai, China · Health and Medical

Source

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Work here? Claim this profile

Overview

HuidaGene Therapeutics is a global clinical-stage biotechnology company based in Shanghai and New Jersey, dedicated to revolutionizing genomic medicine through the development of CRISPR-based gene editing tools and gene therapies.

We address critical patient needs across ophthalmology, neurology, neuro-myology, and otology, leveraging our HG-AAV Platform and Animal Model Platform to develop innovative therapeutic programs.

HuidaGene distinguishes itself through a robust pipeline focused on diseases like RPE65 Mutation-Associated Inherited Retinal Dystrophies, Huntington's Disease, and ALS, driven by a world-class scientific team led by CSO Linyu Shi and supported by a strong Scientific Advisory Board including Hui Yang. Our commitment to advancing genome-editing medicine is transforming the future of treatment for life-threatening conditions.

Most teams do this before shortlisting


Contact Details

+86021-80118181
info@huidagene.com

Shanghai, China

+1

Founded

2018

Company Type

Private Limited Company

Employees

50-100

Keywords

#gene editing

#crispr

#gene therapy

#genome medicine

Companies teams usually look at after HuidaGene Therapeutics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.